Proteomic signature of semaglutide treatment In STEP 1, statistical learning and feature selection were applied to derive a protein signature that distinguished participants receiving semaglutide from participants receiving placebo based on proteomic changes at end of treatment
Jardiance is a Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor
FAERS data carry well-known limitations: reports are voluntary, lack denominators, and cannot establish causation
@chiarthritis Replying to @Lupita_011235 How could a #glp1 treatment help in #inflammatory #arthritis #autoimmune #rheumatoidarthiritis #psoriasis #psoriaticarthritis Can GLP-1 Agonists Help Inflammatory Arthritis
A prespecified nephrology analysis showed a 22% relative risk reduction in the composite renal endpoint (new macro-albuminuria, doubling of serum creatinine, dialysis, or renal death) driven mainly by a 26% fall in new-onset macro-albuminuria [8, 36]
If you stop GLP-1 medications completely, your sugar levels, appetite, and weight may return to pre-treatment levels